Published: 2018-05-23 11:27 | Updated: 2018-05-23 13:34

Yenan Bryceson recently awarded the 2018 Göran Gustafsson prize

Yenan Bryceson. Photo: Jenny MjösbergYenan Bryceson was recently awarded the 2018 Göran Gustafsson prize for medicine. The prize consists of a research grant of SEK 4.5 million plus a personal prize of SEK 250,000. Nominations are received from Sweden’s universities and institutes of advanced studies and managed by the Royal Swedish Academy of Sciences.

Yenan Bryceson conducts research into cytotoxic lymphocytes, which are a type of white blood cell that plays an important role in inflammatory conditions. His research concentrates in particular on hereditary inflammatory diseases that affect children, and there is considerable focus on developing improved diagnostic methods.

– We have recently started to investigate a larger proportion of the genetic material in order to better understand whether mutations outside the cells could be the cause of the diseases, explains Yenan Bryceson.

What does this distinction mean for your research?

– It means a lot! It is a wonderful acknowledgement that will result in opportunities for us to continue our research and to develop diagnostics and therapeutic methods that will benefit patients. It gives us greater freedom and allows us to take more chances,” says Yenan Bryceson.

Congratulations and good luck!

The Göran Gustafsson Prize is awarded annually in five specialised fields: medicine, molecular biology, mathematics, physics and chemistry. The prize for molecular biology was awarded to KI’s researcher, Rickard Sandberg.
Researcher presentations

Link to Yenan’s research group